Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.

Houvenaeghel G, de Nonneville A, Cohen M, Classe JM, Reyal F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo PE, Gimbergues P, Chauvet MP, Azuar AS, Rouzier R, de Lara CT, Muracciole X, Agostini A, Gonçalves A, Lambaudie E.

Breast Cancer Res Treat. 2018 Sep 20. doi: 10.1007/s10549-018-4944-2. [Epub ahead of print]

PMID:
30238274
2.

Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group.

Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Bricou A, Huchon C, Daraï E, Ballester M; Groupe de Recherche FRANCOGYN.

Eur J Surg Oncol. 2018 Jul 31. pii: S0748-7983(18)31256-3. doi: 10.1016/j.ejso.2018.07.053. [Epub ahead of print]

PMID:
30217355
3.

A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group.

Bricou A, Bendifallah S, Daix-Moreux M, Ouldamer L, Lavoue V, Benbara A, Huchon C, Canlorbe G, Raimond E, Coutant C, Graesslin O, Collinet P, Carcopino X, Touboul C, Daraï E, Carbillon L, Ballester M; Groupe de Recherche FRANCOGYN.

Int J Gynecol Cancer. 2018 Sep;28(7):1278-1284. doi: 10.1097/IGC.0000000000001296.

PMID:
29994907
4.

Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer.

Dabi Y, Willecocq C, Ballester M, Carcopino X, Bendifallah S, Ouldamer L, Lavoue V, Canlorbe G, Raimond E, Coutant C, Graesslin O, Collinet P, Bricou A, Huchon C, Daraï E, Haddad B, Touboul C; Groupe de Recherche FRANCOGYN.

J Transl Med. 2018 Jun 14;16(1):163. doi: 10.1186/s12967-018-1531-6.

5.

Breast Cancer Blood Flow and Metabolism on Dual-Acquisition 18F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy Response.

Humbert O, Lasserre M, Bertaut A, Fumoleau P, Coutant C, Brunotte F, Cochet A.

J Nucl Med. 2018 Jul;59(7):1035-1041. doi: 10.2967/jnumed.117.203075. Epub 2018 Feb 9.

PMID:
29439010
6.

Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries.

Cortet M, Bertaut A, Molinié F, Bara S, Beltjens F, Coutant C, Arveux P.

BMC Cancer. 2018 Feb 7;18(1):161. doi: 10.1186/s12885-018-4080-8.

7.

Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN group.

Rousselin A, Bendifallah S, Nyangoh Timoh K, Ouldamer L, Canlorbe G, Raimond E, Hudry N, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Levêque J, Lavoue V.

Eur J Surg Oncol. 2017 Nov;43(11):2135-2142. doi: 10.1016/j.ejso.2017.07.019. Epub 2017 Aug 9.

8.

Prognostic value of local relapse for patients with endometrial cancer.

Dabi Y, Uzan J, Bendifallah S, Ouldamer L, Lavoué V, Canlorbe G, Raimond E, Coutant C, Graesslin O, Collinet P, Bricou A, Daraï E, Ballester M, Haddad B, Touboul C; Groupe de Recherche FRANCOGYN.

Eur J Surg Oncol. 2017 Nov;43(11):2143-2149. doi: 10.1016/j.ejso.2017.08.004. Epub 2017 Aug 31.

PMID:
28870426
9.

Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms.

Hermans A, Abend AM, Kesisoglou F, Flanagan T, Cohen MJ, Diaz DA, Mao Y, Zhang L, Webster GK, Lin Y, Hahn DA, Coutant CA, Grady H.

AAPS J. 2017 Nov;19(6):1537-1549. doi: 10.1208/s12248-017-0117-1. Epub 2017 Aug 22.

PMID:
28831727
10.

Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer.

Gonssaud B, Goussot V, Berriolo-Riedinger A, Saïtta-Aribau E, Coutant C, Cochet A, Fumoleau P, Riedinger JM.

Ann Biol Clin (Paris). 2017 Aug 1;75(4):421-429. doi: 10.1684/abc.2017.1257.

PMID:
28751287
11.

Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer.

Chenoz L, Phelippeau J, Barranger E, Bourdel N, Brun JL, Chereau E, Collinet P, Coutant C, Darai E, Deffieux X, Gautier T, Golfier F, Huchon C, Ouldamer L, Rouzier R, Koskas M.

Int J Gynecol Cancer. 2017 Jun;27(5):979-986. doi: 10.1097/IGC.0000000000000980.

PMID:
28498258
12.

Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).

Houvenaeghel G, Lambaudie E, Cohen M, Classe JM, Reyal F, Garbay JR, Giard S, Chopin N, Martinez A, Rouzier R, Daraï E, Colombo PE, Coutant C, Gimbergues P, Azuar P, Villet R, Tunon de Lara C, Barranger E, Sabiani L, Goncalves A.

Breast. 2017 Aug;34:24-33. doi: 10.1016/j.breast.2017.04.008. Epub 2017 May 3.

PMID:
28475932
13.

Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study.

Rouzier R, Uzan C, Rousseau A, Guillot E, Zilberman S, Meyer C, Estevez P, Dupre PF, Kere D, Doridot V, D'halluin G, Fritel X, Pouget N, Jankowski C, Mazouni C, Simon T, Coutant C.

Br J Cancer. 2017 Apr 25;116(9):1135-1140. doi: 10.1038/bjc.2017.47. Epub 2017 Mar 21.

14.

Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.

Bendifallah S, Perrin M, Ouldamer L, Lavoué V, Canlorbe G, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Collinet P, Daraï E, Ballester M; FRANCOGYN study group.

Surg Oncol. 2017 Mar;26(1):1-7. doi: 10.1016/j.suronc.2016.11.001. Epub 2016 Nov 14.

15.

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.

de Nonneville A, Gonçalves A, Zemmour C, Classe JM, Cohen M, Lambaudie E, Reyal F, Scherer C, Muracciole X, Colombo PE, Giard S, Rouzier R, Villet R, Chopin N, Darai E, Garbay JR, Gimbergues P, Sabiani L, Coutant C, Sabatier R, Bertucci F, Boher JM, Houvenaeghel G.

Breast Cancer Res Treat. 2017 Apr;162(2):307-316. doi: 10.1007/s10549-017-4136-5. Epub 2017 Feb 2.

PMID:
28155054
16.

Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.

Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Daraï E, Ballester M; Groupe de Recherche FRANCOGYN.

Ann Surg Oncol. 2017 Jun;24(6):1660-1666. doi: 10.1245/s10434-016-5731-0. Epub 2017 Jan 5.

PMID:
28058558
17.

[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]].

Delaloge S, Bachelot T, Bidard FC, Espie M, Brain E, Bonnefoi H, Gligorov J, Dalenc F, Hardy-Bessard AC, Azria D, Jacquin JP, Lemonnier J, Jacot W, Goncalves A, Coutant C, Ganem G, Petit T, Penault-Llorca F, Debled M, Campone M, Levy C, Coudert B, Lortholary A, Venat-Bouvet L, Grenier J, Bourgeois H, Asselain B, Arvis J, Castro M, Tardivon A, Cox DG, Arveux P, Balleyguier C, André F, Rouzier R; Intergroupe national de recherche sur le cancer du sein Unicancer (UCBG).

Bull Cancer. 2016 Nov;103(11):951-952. doi: 10.1016/j.bulcan.2016.10.009. Epub 2016 Oct 28. French. No abstract available.

PMID:
28029350
18.

Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.

Poupon C, Bendifallah S, Ouldamer L, Canlorbe G, Raimond E, Hudry N, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Levêque J, Lavoue V.

Ann Surg Oncol. 2017 Jun;24(6):1667-1676. doi: 10.1245/s10434-016-5735-9. Epub 2016 Dec 22.

19.

Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.

Ouldamer L, Bendifallah S, Body G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Daraï E, Ballester M.

Br J Cancer. 2016 Nov 22;115(11):1296-1303. doi: 10.1038/bjc.2016.337. Epub 2016 Nov 8.

20.

Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis.

Jankowski C, Guiu S, Cortet M, Charon-Barra C, Desmoulins I, Lorgis V, Arnould L, Fumoleau P, Coudert B, Rouzier R, Coutant C, Reyal F.

Breast Cancer Res Treat. 2017 Jan;161(1):73-81. doi: 10.1007/s10549-016-4040-4. Epub 2016 Nov 2.

PMID:
27807808
21.

Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.

Bendifallah S, Ouldamer L, Lavoue V, Canlorbe G, Raimond E, Coutant C, Graesslin O, Touboul C, Collinet P, Daraï E, Ballester M; Groupe de Recherche FRANCOGYN.

Gynecol Oncol. 2017 Jan;144(1):107-112. doi: 10.1016/j.ygyno.2016.10.025. Epub 2016 Oct 25.

PMID:
27789083
22.

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Eliade M, Skrzypski J, Baurand A, Jacquot C, Bertolone G, Loustalot C, Coutant C, Guy F, Fumoleau P, Duffourd Y, Arnould L, Delignette A, Padéano MM, Lepage C, Raichon-Patru G, Boudrant A, Bône-Lépinoy MC, Villing AL, Charpin A, Peignaux K, Chevrier S, Vegran F, Ghiringhelli F, Boidot R, Sevenet N, Lizard S, Faivre L.

Oncotarget. 2017 Jan 10;8(2):1957-1971. doi: 10.18632/oncotarget.12699.

23.

Breast cancer in young women: Pathologic features and molecular phenotype.

Sabiani L, Houvenaeghel G, Heinemann M, Reyal F, Classe JM, Cohen M, Garbay JR, Giard S, Charitansky H, Chopin N, Rouzier R, Daraï E, Coutant C, Azuar P, Gimbergues P, Villet R, Tunon de Lara C, Lambaudie E.

Breast. 2016 Oct;29:109-16. doi: 10.1016/j.breast.2016.07.007. Epub 2016 Jul 29.

PMID:
27479041
24.

[Breast cancer screening: On our way to the future].

Delaloge S, Bachelot T, Bidard FC, Espie M, Brain E, Bonnefoi H, Gligorov J, Dalenc F, Hardy-Bessard AC, Azria D, Jacquin JP, Lemonnier J, Jacot W, Goncalves A, Coutant C, Ganem G, Petit T, Penault-Llorca F, Debled M, Campone M, Levy C, Coudert B, Lortholary A, Venat-Bouvet L, Grenier J, Bourgeois H, Asselain B, Arvis J, Castro M, Tardivon A, Cox DG, Arveux P, Balleyguier C, André F, Rouzier R; Intergroupe national de recherche sur le cancer du sein Unicancer (UCBG).

Bull Cancer. 2016 Sep;103(9):753-63. doi: 10.1016/j.bulcan.2016.06.005. Epub 2016 Jul 26. Review. French.

PMID:
27473920
25.

[Non-metastatic triple-negative breast cancer in 2016: Definitions and management].

Portha H, Jankowski C, Cortet M, Desmoulins I, Martin E, Lorgis V, Arnould L, Coutant C.

Gynecol Obstet Fertil. 2016 Sep;44(9):492-504. doi: 10.1016/j.gyobfe.2016.06.014. Epub 2016 Jul 19. Review. French.

PMID:
27451066
26.

Atypical epithelial hyperplasia of the breast: state of the art.

Dion L, Racin A, Brousse S, Beltjens F, Cauchois A, Levêque J, Coutant C, Lavoué V.

Expert Rev Anticancer Ther. 2016 Sep;16(9):943-53. doi: 10.1080/14737140.2016.1204916. Epub 2016 Jul 5. Review.

27.

[Ductal carcinoma in situ diagnosis: 3 French national guidelines].

Cutuli B, Tunon De Lara C, Arnaud A, Bertheau P, Boulanger L, Boute V, Ceugnart L, Chauvet MP, Coutant C, De Cremoux P, Fourquet A, Hennequin C, Lesieur A, Lesur A, Lévy L, Vincent-Salomon A, Besnard S, Belorgey C.

Ann Pathol. 2016 Jun;36(3):166-73. doi: 10.1016/j.annpat.2016.03.012. Epub 2016 May 25. French.

PMID:
27236350
28.

[Assessment of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy in breast cancer: before or after?].

Coutant C, Jankowski C, Portha H, Barranger E.

Gynecol Obstet Fertil. 2016 Jun;44(6):345-9. doi: 10.1016/j.gyobfe.2016.04.010. Epub 2016 May 24. Review. French.

PMID:
27234216
29.

[CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3].

Riedinger JM, Goussot V, Desmoulins I, Lorgis V, Coutant C, Beltjens F, Lizard S, Fumoleau P.

Bull Cancer. 2016 May;103(5):434-43. doi: 10.1016/j.bulcan.2016.02.003. Epub 2016 Mar 8. French.

PMID:
26969424
30.

Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.

Lavoué V, Fritel X, Antoine M, Beltjens F, Bendifallah S, Boisserie-Lacroix M, Boulanger L, Canlorbe G, Catteau-Jonard S, Chabbert-Buffet N, Chamming's F, Chéreau E, Chopier J, Coutant C, Demetz J, Guilhen N, Fauvet R, Kerdraon O, Laas E, Legendre G, Mathelin C, Nadeau C, Naggara IT, Ngô C, Ouldamer L, Rafii A, Roedlich MN, Seror J, Séror JY, Touboul C, Uzan C, Daraï E; French College of Gynecologists and Obstetricians (CNGOF).

Eur J Obstet Gynecol Reprod Biol. 2016 May;200:16-23. doi: 10.1016/j.ejogrb.2016.02.017. Epub 2016 Feb 28.

31.

Determinants of quality of life among long-term breast cancer survivors.

Chu WO, Dialla PO, Roignot P, Bone-Lepinoy MC, Poillot ML, Coutant C, Arveux P, Dabakuyo-Yonli TS.

Qual Life Res. 2016 Aug;25(8):1981-90. doi: 10.1007/s11136-016-1248-z. Epub 2016 Feb 25.

PMID:
26914102
32.

Patient age and breast resection weight affect immediate postmastectomy breast reconstruction in ductal carcinoma in situ.

Burnier P, Hudry D, See LA, Duvernay A, Roche M, Loustalot C, Zwetyenga N, Coutant C.

J Plast Reconstr Aesthet Surg. 2016 Jan;69(1):37-41. doi: 10.1016/j.bjps.2015.09.023. Epub 2015 Oct 14.

PMID:
26576701
33.

[Benign proliferative breast disease with and without atypia].

Coutant C, Canlorbe G, Bendifallah S, Beltjens F.

J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):980-95. doi: 10.1016/j.jgyn.2015.09.037. Epub 2015 Nov 3. Review. French.

34.

[Benign breast tumors: Recommendations of Collège National des Gynécologues Obstétriciens Français (CNGOF)--Short text].

Lavoué V, Fritel X, Antoine M, Beltjens F, Bendifallah S, Boisserie-Lacroix M, Boulanger L, Canlorbe G, Catteau-Jonard S, Chabbert-Buffet N, Chamming's F, Chéreau E, Chopier J, Coutant C, Demetz J, Guilhen N, Fauvet R, Kerdraon O, Laas E, Legendre G, Mathelin C, Nadeau C, Thomassin Naggara I, Ngô C, Ouldamer L, Rafii A, Roedlich MN, Seror J, Séror JY, Touboul C, Uzan C, Daraï E; Collège national des gynécologues obstétriciens français.

J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):1049-64. doi: 10.1016/j.jgyn.2015.09.033. Epub 2015 Nov 2. Review. French.

35.

[Clinical practice guidelines: Benign breast tumor--Aims, methods and organization].

Lavoué V, Fritel X, Chopier J, Roedlich MN, Chamming's F, Mathelin C, Bendifallah S, Boisserie-Lacroix M, Canlorbe G, Chabbert-Buffet N, Coutant C, Guilhen N, Fauvet R, Laas E, Legendre G, Thomassin Naggara I, Ngô C, Ouldamer L, Seror J, Touboul C, Daraï E; French College of Obstetricians and Gynecologists.

J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):898-903. doi: 10.1016/j.jgyn.2015.09.044. Epub 2015 Oct 31. French.

36.

[Lobular invasive breast cancer prognostic factors: About 940 patients].

Jauffret C, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Bélichard C, Faure C, Darai É, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Coutant C, Dravet F, Chauvet MP, Chéreau Ewald E, Penault-Llorca F, Goncalves A, Lambaudie É.

Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16. French.

PMID:
26482833
37.

[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer].

Konan S, Goussot V, Desmoulins I, Lorgis V, Coutant C, Fumoleau P, Beltjens F, Dalban C, Lizard S, Riedinger JM.

Bull Cancer. 2015 Oct;102(10):834-44. doi: 10.1016/j.bulcan.2015.07.011. Epub 2015 Sep 28. French.

PMID:
26422277
38.

Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma.

Delpech Y, Bashour SI, Lousquy R, Rouzier R, Hess K, Coutant C, Barranger E, Esteva FJ, Ueno NT, Pusztai L, Ibrahim NK.

Br J Cancer. 2015 Sep 29;113(7):1003-9. doi: 10.1038/bjc.2015.308. Epub 2015 Sep 22.

39.

Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Humbert O, Riedinger JM, Charon-Barra C, Berriolo-Riedinger A, Desmoulins I, Lorgis V, Kanoun S, Coutant C, Fumoleau P, Cochet A, Brunotte F.

Clin Cancer Res. 2015 Dec 15;21(24):5460-8. doi: 10.1158/1078-0432.CCR-15-0384. Epub 2015 Jun 30.

40.

Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling.

Ding X, Gueorguieva I, Wesley JA, Burns LJ, Coutant CA.

AAPS J. 2015 Nov;17(6):1395-406. doi: 10.1208/s12248-015-9797-6. Epub 2015 Jul 1.

41.

Evaluation of axillary involvement by ultrasound-guided lymph node biopsy: A prospective study.

Jankowski C, Hudry D, Vaillant D, Varbedian O, Mejean N, Guy F, Feutray S, Coutant C.

Gynecol Obstet Fertil. 2015 Jun;43(6):431-6. doi: 10.1016/j.gyobfe.2015.04.007. Epub 2015 May 16.

PMID:
25986396
42.

Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study.

Canlorbe G, Bendifallah S, Laas E, Raimond E, Graesslin O, Hudry D, Coutant C, Touboul C, Bleu G, Collinet P, Cortez A, Daraï E, Ballester M.

Ann Surg Oncol. 2016 Jan;23(1):171-7. doi: 10.1245/s10434-015-4583-3. Epub 2015 May 8.

PMID:
25952272
43.

Impact of age-related socio-economic and clinical determinants of quality of life among long-term breast cancer survivors.

Dialla PO, Chu WO, Roignot P, Bone-Lepinoy MC, Poillot ML, Coutant C, Arveux P, Dabakuyo-Yonli TS.

Maturitas. 2015 Jul;81(3):362-70. doi: 10.1016/j.maturitas.2015.03.025. Epub 2015 Apr 8.

PMID:
25911244
44.

A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.

Bendifallah S, Canlorbe G, Laas E, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Collinet P, Cortez A, Bleu G, Daraï E, Ballester M.

Ann Surg Oncol. 2015 Dec;22(13):4224-32. doi: 10.1245/s10434-015-4548-6. Epub 2015 Apr 14.

PMID:
25869227
45.

Just how accurate are the major risk stratification systems for early-stage endometrial cancer?

Bendifallah S, Canlorbe G, Collinet P, Arsène E, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Daraï E, Ballester M.

Br J Cancer. 2015 Mar 3;112(5):793-801. doi: 10.1038/bjc.2015.35. Epub 2015 Feb 12.

46.

French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring System.

Bendifallah S, Canlorbe G, Arsène E, Collinet P, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Daraï E, Ballester M.

Ann Surg Oncol. 2015 Aug;22(8):2722-8. doi: 10.1245/s10434-014-4311-4. Epub 2015 Jan 7.

PMID:
25564162
47.

Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.

Canlorbe G, Bendifallah S, Raimond E, Graesslin O, Hudry D, Coutant C, Touboul C, Bleu G, Collinet P, Darai E, Ballester M.

Ann Surg Oncol. 2015 Aug;22(8):2714-21. doi: 10.1245/s10434-014-4295-0. Epub 2014 Dec 12.

48.

[Endometrial carcinoma. Application of the guidelines of 2010: multicentre trial].

Raimond E, Canlorbe G, Bendifallah S, Hudry D, Selvi F, Ballester M, Coutant C, Graesslin O, Daraï E.

Bull Cancer. 2014 Jul-Aug;101(7-8):703-13. doi: 10.1684/bdc.2014.1955. French.

PMID:
25091653
49.

External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study.

Bendifallah S, Canlorbe G, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Huguet F, Cortez A, Daraï E, Ballester M.

Am J Obstet Gynecol. 2015 Jan;212(1):56.e1-7. doi: 10.1016/j.ajog.2014.06.058. Epub 2014 Jun 28.

PMID:
24983678
50.

A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.

Bendifallah S, Canlorbe G, Huguet F, Coutant C, Hudry D, Graesslin O, Raimond E, Touboul C, Collinet P, Bleu G, Daraï E, Ballester M.

Ann Surg Oncol. 2014 Dec;21(13):4239-45. doi: 10.1245/s10434-014-3864-6. Epub 2014 Jun 27.

PMID:
24969441

Supplemental Content

Loading ...
Support Center